Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Pat Larrabee
Title
Founder and President, Facility Logix
Bio
Pat Larrabee is the Founder and President of Facility Logix, an owner’s representative and management consulting firm for biotechnology and life sciences companies. With more than 30 years of experience in the biotechnology industry, Pat applies biotech and facility management expertise to address the facility-related needs of biotechnology companies, public and private institutions, economic development organizations, and commercial real estate firms and developers. She advises clients across the country as both an owner’s rep and project manager for major biotech and life sciences facility expansions.
Many growing life science clusters trust Facility Logix to help plan and develop communities of innovation and biotech ecosystems that attract industry and develop the workforce. Facility Logix offers facility project management, feasibility studies, and market positioning/strategic operational analyses as core services, while facilitating collaboration with industry partners and providing value-add to brokers and commercial real estate firms. The firm serves clients such as Johns Hopkins University, United Therapeutics, bluebird bio, George Mason University, Integrated Biotherapeutics, Eisai, MaxCyte, the Mayo Clinic and the Wisconsin Alumni Research Foundation.
Many growing life science clusters trust Facility Logix to help plan and develop communities of innovation and biotech ecosystems that attract industry and develop the workforce. Facility Logix offers facility project management, feasibility studies, and market positioning/strategic operational analyses as core services, while facilitating collaboration with industry partners and providing value-add to brokers and commercial real estate firms. The firm serves clients such as Johns Hopkins University, United Therapeutics, bluebird bio, George Mason University, Integrated Biotherapeutics, Eisai, MaxCyte, the Mayo Clinic and the Wisconsin Alumni Research Foundation.
